T. Rowe Price Associates »

Perspective Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 15k 0.00

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Intuitive Surgical Comm Stk (ISRG)
Elevance Health Comm Stk (ELV)
Schwab Charles Corp Comm Stk (SCHW)

View all positions for T. Rowe Price Associates

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics